ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,687.58
      -1.05%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cidara Therapeutics Inc (CDTX)

      7. Cidara Therapeutics Inc (CDTX) Financials

      Cidara Therapeutics Inc

      Cidara Therapeutics Inc (CDTX)

      NASDAQ
      12.05
      0.04
      (0.33%)
      Closed July 07 4:00PM
      Delayed by 15 minutes
      12.04
      -0.01
      (-0.08%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Cidara Therapeutics Inc Financial Summary

      The current CDTX market cap is 54.97M. The company's latest EPS is USD -5.0268 and P/E is -2.40.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 25.99M7.61M12.72M17.58M8.46M
      Operating Income 2.98M-12.83M-8.56M-6.07M-10.69M
      Net Income 2.53M-11.68M-8.17M-5.61M-10.33M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 20.92M12.07M49.57M64.29M63.91M
      Operating Income -41.72M-71.85M-42.26M-29.72M-24.48M
      Net Income -41.09M-74.87M-42.47M-29.8M-22.93M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 81.74M67.99M63.47M67.03M52.72M
      Total Liabilities 54.9M52.57M55.43M75.24M70.5M
      Total Equity 26.84M15.41M8.04M-8.21M-17.78M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 68.98M60.42M75.33M47.59M67.03M
      Total Liabilities 31.14M49.71M53.75M50.5M75.24M
      Total Equity 37.84M10.72M21.57M-2.9M-8.21M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -10.9M-8.08M-9.71M-22.43M-6.64M
      Investing -94k-201k-327k-505k-23k
      Financing 26.24M25.98M25.98M25.98M-93k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -28.53M-54.41M-25.23M-28.47M-22.43M
      Investing -35k-186k-41k-118k-505k
      Financing 14.27M37.28M44.6M-951k25.98M

      Stats and Ratios

      Market Cap 54.97M
      Price to Earnings Ratio -2.40
      Price to Sales Ratio 0.86
      Price to Cash Ratio 1.54
      Price to Book Ratio -6.69
      Dividend Yield -

      Share Statistics

      Shares Outstanding 4.56M
      Average Volume (1 week) 36.88k
      Average Volume (1 Month) 50.94k
      52 Week Change -46.21%
      52 Week High 24.40
      52 Week Low 10.004
      Spread (Intraday) 4.55 (30.33%)

      Company Info

      Company Name Cidara Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.cidara.com
      Industry biological pds,ex diagnstics (2836)